Skip to content

Effects of Tegileridine used for postoperative analgesia on the quality of postoperative recovery in elderly patients with colorectal tumors

Effects of Tegileridine used for postoperative analgesia on the quality of postoperative recovery in elderly patients with colorectal tumors

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115217
Enrollment
Unknown
Registered
2025-12-23
Start date
2025-12-25
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal tumors

Interventions

Sponsors

Guangxi Medical University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age: 60 years old to 85 years old; 2. BMI: 18 kg/m^2 to 28 kg/m^2; 3. Patients planning to undergo laparoscopic resection of colorectal tumors; 4. ASA classification: Grade II-III; 5. Signed the informed consent form for this study (by oneself or legal representative).

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to the drugs used in this study; 2 .Patients with contraindications for transversus abdominis plane block; 3 .Individuals with communication or cognitive dysfunction; 4. Those who have been taking opioid drugs for a long time; 5. Those with abnormal pain perception function; 6. Patients with severe respiratory diseases; 7. Patients with severe liver and kidney dysfunction; 8. Known or suspected gastrointestinal obstruction (including paralytic ileus).

Design outcomes

Primary

MeasureTime frame
Quality scores were recovered the first day after surgery;

Secondary

MeasureTime frame
Postoperative nausea and vomiting;The recovery status of gastrointestinal function;NRS of pain scores (at rest/ during turning over);Other adverse reactions after the surgery;Quality scores were recovered the orther day after surgery;Incidence of delirium;Degree of sedation;Inflammatory response indicators;

Countries

China

Contacts

Public ContactFei Lin

Guangxi Medical University Cancer Hospital

linfei@gxmu.edu.cn+86 137 0788 6172

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026